1492 Organometallics, Vol. 27, No. 7, 2008
Synthesis of Ligands and 8. (3,4,5-(CH3O)3C6H2)
Scarel et al.
6
Synthesis of Complexes. All manipulations were carried out
under argon atmosphere with Schlenk technique and at room
temperature.
(3,5-(CF3)2C6H3)-BIAN (8). To a 100 mL Schlenk flask under N2
and with magnetic stirring were added at room temperature (3,5-
(CF3)2C6H3-BIAN)ZnCl2 (460 mg, 0.63 mmol),24 3,4,5-
(CH3O)3C6H2NH2 (120 mg, 0.66 mmol), and methanol (20 mL).
The complex completely dissolved. The reaction was monitored
by TLC (alumina, CH2Cl2). To do so, a 0.5 mL aliquot of the
solution was withdrawn and coordinated ZnCl2 was eliminated by
the method detailed below for the final product. The reaction
terminated after 2 h, during which time the solution turned from
orange to red. At this stage, a precipitate had formed, but the
solution still contained appreciable amounts of the product, so the
suspension was evaporated in vacuo and the solid washed with a
1:1 hexane/toluene mixture (10 mL) to remove the free anilines.
To eliminate the coordinated ZnCl2, the solid was dissolved in
CH2Cl2 (25 mL) in a separating funnel and shaken with a saturated
K2C2O4 aqueous solution (10 mL) for 10 min. The organic phase
was separated, washed with water (3 × 10 mL), dried with Na2SO4,
and evaporated in vacuo. The obtained solid was purified by column
chromatography on silica, using 10:0.5 hexane/triethylamine as
eluent. Ligand 8 was eluted first (85 mg, 24% yield), followed by
a small amount of 6. However, the latter compound is better
prepared as described in the next paragraph. Anal. Calcd for
C29H20F6N2O3: C, 62.37, H, 3.61, N, 5.02. Found: C, 61.99, H,
3.50, N, 5.10.
Synthesis of Neutral Complexes [Pd(CH3)(Cl)(N-N)] (1a–
8a). All the complexes were prepared starting from [Pd(Cl)2(cod)],
following the procedure reported in the literature.29,47 In particular,
1.1 equiv of N-N ligand was added to 0.40 mmol of
[Pd(CH3)(Cl)(cod)], dissolved in dichloromethane, at room tem-
perature. After 1 h, diethyl ether was added and the product
precipitated as a red-orange solid. Average yield: 94%.
[Pd(CH3)(Cl)(1)] (1a). Elemental Anal. Calcd for C25H19ClN2Pd:
1
C, 61.37; H, 3.91, N, 5.73. Found: C, 61.11; H, 3.78; N, 5.67. H
NMR (400 MHz, CD2Cl2, 298 K): δ 8.04 (dd, 2H, H5,8), 7.61 (t,
2H, H15′,17′), 7.55 (t, 2H, H15,17), 7.51–7.40 (m, 4H, H4,9 and
H16,16′), 7.38 (d, 2H, H14,18), 7.23 (d, 2H, H14′,18′), 7.16 (d, 1H,
H3), 6.54 (d, 1H, H10), 0.91 (s, 3H, CH3-Pd).
[Pd(CH3)(Cl)(2)] (2a). Elemental Anal. Calcd for C27H23ClN2Pd:
1
C, 62.68; H, 4.48, N, 5.41. Found: C, 62.40; H, 4.30; N, 4.97. H
NMR (400 MHz, CD2Cl2, 298 K): δ 8.04 (dd, 2H, H5,8), 7.50–7.41
(m, 4H, H4,9 and H17,17′), 7.29–7.14 (m, 5H, H16,18,16′,18′ e H14),
7.01 (m, 2H, H14′ and H3), 6.58 (d, 1H, H10), 2.47 (s, 3H, CH3-
Ph), 2.44 (s, 3H, CH3-Ph), 0.91 (s, 3H, CH3-Pd).
[Pd(CH3)(Cl)(3)] (3a). Elemental Anal. Calcd for
C27H17ClF6N2Pd: C, 51.86; H, 2.74, N, 4.48. Found: C, 52.06; H,
1
2.65; N, 4.60. H NMR (400 MHz, CD2Cl2, 298 K): δ 8.16 (dd,
2H, H5,8), 7.80–7.46 (m, 6H, H16,17,18,16′,17′,18′), 7.64 (s, 2H,
H14,14′), 7.53–7.46 (m, H4,9), 7.16 (d, 1H, H3), 6.56 (d, 1H, H10),
0.90 (s, 3H, CH3-Pd).
As for all other known asymmetric Ar′,Ar-BIAN compounds,
the free ligand is present in solution as a mixture of the anti-anti
and syn-anti isomers, with the former prevailing.27
[Pd(CH3)(Cl)(4)] (4a). Elemental Anal. Calcd for C29H27ClN2Pd:
1
C, 63.86; H, 4.99, N, 5.14. Found: C, 63.70; H, 4.66; N, 5.12. H
NMR (400 MHz, CD2Cl2, 298 K): δ 8.03 (dd, 2H, H5,8), 7.45 (dt,
2H, H4,9), 7.16 (d, 1H, H3), 7.08 (s, 1H, H16′), 7.02 (s, 1H, H16),
6.95 (s, 2H, H14,18), 6.81 (s, 2H, H14′,18′), 6.62 (d, 1H, H10), 2.41
(s, 6H, 15′,17′-(CH3)2-Ph), 2.39 (s, 6H, 15,17-(CH3)2-Ph), 0.91 (s,
3H, CH3-Pd).
[Pd(CH3)(Cl)(5)] (5a). Elemental Anal. Calcd for
C29H15ClF12N2Pd: C, 45.75; H, 1.99, N, 3.68. Found: C, 45.50; H,
1
The ratio between the two isomers calculated from both the 1H
and the 19F NMR is 8:1, which is comparable to that found for
other ligands of the same class.27 For the minor isomer, only some
signals could be clearly assigned in the 1H NMR spectrum and are
reported below.
1.96; N, 3.92. H NMR (400 MHz, CD2Cl2, 298 K): δ 8.22 (dd,
2H, H5,8), 8.09 (s, 1H, H16′), 8.01 (s, 1H, H16), 7.92 (s, 2H, H14,18),
7.83 (s, 2H, H14′,18′), 7.58 (dt, 2H, H4,9), 7.21 (d, 1H, H3), 6.63 (d,
1H, H10), 0.77 (s, 3H, CH3-Pd).
[Pd(CH3)(Cl)(6)] (6a). Elemental Anal. Calcd for
C31H31ClO6N2Pd: C, 55.62; H, 4.67; N, 4.18. Found: C, 55.35; H,
Major isomer (anti-anti). 1H NMR (CDCl3, 298 K) δ 8.00 (d,
J ) 7.6 Hz, 1H, H5), 7.96 (d, J ) 7.63 Hz, 1H, H8), 7.80 (s, 1H,
H16), 7.62 (s, 2H, H14, H18), 7.52 (pst, H9), 7.47 (pst, H4), 7.20 (d,
J ) 7.2 Hz, 1H, H10), 6.82 (d, J ) 7.2 Hz, 1H, H3), 6.40 (s, 2H,
H14′, H18′), 3.96 (s, 3H, p-OCH3), 3.86 (s, 6H, m-OCH3). 19F NMR
(CDCl3, 298 K) δ -63.2 (s, CF3).
1
4.55; N, 4.00. H NMR (400 MHz, CD2Cl2, 298 K): δ 8.11 (dd,
2H, H5,8), 7.55 (dd, 2H, H4,9), 7.44 (d, 1H, H3), 6.81 (d, 1H, H10),
6.66 (s, 2H, Hortho cis to Pd-Cl), 6.48 (s, 2H, Hortho cis to Pd-
CH3), 3.90 (s, 6H, OCH3 para), 3.86 (s, 6H, OCH3 meta), 3.84 (s,
6H, OCH3 meta), 0.87 (s, 3H, CH3-Pd).
[Pd(CH3)(Cl)(7)] (7a). Elemental Anal. Calcd for
C29H15ClF6N2Pd: C, 53.31; H, 3.24, N, 4.29. Found: C, 53.50; H,
1
Minor isomer (syn-anti. H NMR (CDCl3, 298 K) δ 6.00 (s,
2H, H14′, H18′), 3.86 (s, 3H, p-OCH3), 3.74 (s, 6H, m-OCH3). 19F
NMR (CDCl3, 298 K) δ -63.07 (s, CF3).
1
2.96; N, 3.92. H NMR (400 MHz, CD2Cl2, 298 K): δ 8.12 (dd,
2H, H5,8), 7.93 (s, 1H, H16), 7.89 (s, 2H, H14,18), 7.52 (dt, 2H,
H4,9), 7.11 (m, 2H, H16′ and H3), 6.81 (s, 2H, H14′,18′), 6.67 (d,
1H, H10), 2.43 (s, 6H, 15′,17′-(CH3)2-Ph), 1.01 (s, 3H, CH3-Pd
major isomer, it is trans to the aryl ring substituted with CF3), 0.79
(s, 3H, CH3-Pd minor isomer, it is trans to the aryl ring substituted
with CH3), in the aromatic region also the signals due to the minor
isomer are visible, with the ratio between the two isomers 10/1.
[Pd(CH3)(Cl)(8)] (8a). Elemental Anal. Calcd for
C30H23ClF6N2O3Pd: C, 50.37; H, 3.24, N, 3.91. Found: C, 40.95;
H, 3.06; N, 3.92. 1H NMR (400 MHz, CD2Cl2, 298 K): δ 8.16 (d,
2H, H5,8), 7.80 (s, 1H, H16), 7.90 (s, 2H, H14,18), 7.55 (m, 2H,
H4,9), 7.15 (d, 1H, H3), 6.88 (d, 1H, H10), 6.49 (s, 2H, H14′,18′),
3.90 (s, 3H, OCH3 para), 3.88 (s, OCH3 meta, minor isomer), 3.85
(s, 6H, OCH3 meta, major isomer), 0.95 (s, 3H, CH3-Pd major
(3,4,5-(CH3O)3C6H2)2-BIAN (6). To a 100 mL Schlenk flask
under N2 and with magnetic stirring were added at room temperature
(3,5-(CF3)2C6H3-BIAN)ZnCl2 (305.5 mg, 0.412 mmol), 3,4,5-
(CH3O)3C6H2NH2 (227.3 mg, 1.241 mmol), and methanol (20 mL).
The complex completely dissolved. The reaction was stirred at room
temperature overnight, during which time the solution turned from
orange to red and a red precipitate formed. The solid was collected
by filtration and washed with hexane (3 × 10 mL) to remove any
free amine. The free ligand was obtained by the same procedure
described for 8, but in this case no chromatographic purification
was necessary and the ligand is obtained analytically pure (126.7
mg, 60.0% yield). Anal. Calcd for C30H28N2O6: C, 70.30, H, 5.51,
N, 5.47. Found: C, 70.01, H, 5.80, N, 5.12.
1H NMR (CDCl3, 298 K) δ 7.97 (d, J ) 8.3 Hz, 2H, H5), 7.47
(pst, J ) 7.9 Hz, 2H, H4), 7.12 (d, J ) 7.2 Hz, 2H, H3), 6.40 (s,
4H, H14,18), 3.96, (s, 2H, p-OCH3), 3.85 (s, 4H, m-OCH3).
(47) Milani, B.; Marson, A.; Zangrando, E.; Mestroni, G.; Ernsting, J. M.;
Elsevier, C. J. Inorg. Chim. Acta 2002, 327, 188–201.